Literature DB >> 11246313

Hyperprocalcitonemia in patients with perioperative myocardial infarction after cardiac surgery.

J B Lecharny1, D Khater, R Bronchard, I Philip, G Durand, J M Desmonts, M Dehoux.   

Abstract

OBJECTIVE: To describe and compare procalcitonin (PCT) concentrations after cardiac surgery in uncomplicated patients and in patients with perioperative myocardial infarction (PMI).
DESIGN: Retrospective comparative study.
SETTING: One university hospital. PATIENTS: Fifty-eight adult patients undergoing cardiac surgery. INTERVENTION: None.
MEASUREMENTS AND MAIN RESULTS: In a first step, plasma PCT and C-reactive protein concentrations were measured preoperatively and until 72 hrs postoperatively in ten consecutive patients who underwent uncomplicated cardiac surgery. PCT concentrations increased progressively from the end of cardiopulmonary bypass (0.09 +/- 0.09 ng/mL), peaked at 24 hrs postoperatively (1.14 +/- 1.24 ng/mL), and began to decrease at 48 hrs. C-reactive protein appeared to peak at 48 hrs (from 5.8 +/- 11.7 mg/L preoperatively to 265.1 +/- 103.5 mg/L on the second postoperative day). In a second step, PCT concentrations were measured at day one in 23 patients (PMI group) who presented high postoperative plasma cardiac troponin I concentrations and were compared with PCT concentrations observed in 25 matched uncomplicated patients. All patients were free from infection. PCT in the PMI group was significantly higher than in the control group (27.1 +/- 63.2 vs. 2.0 +/- 2.4 ng/mL, respectively; p =.0053).
CONCLUSION: Because high plasma concentrations of PCT were found in patients with PMI after cardiac surgery, it may be suggested that, in the early postoperative period, elevated plasma PCT concentrations should be interpreted with caution regarding infection diagnosis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11246313     DOI: 10.1097/00003246-200102000-00019

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  7 in total

1.  Serum Procalcitonin Levels are Associated with Clinical Outcome in Intracerebral Hemorrhage.

Authors:  Dingxiu He; Yun Zhang; Biao Zhang; Wei Jian; Xiaojian Deng; Yi Yang; Tao Xiao; Hanyang Yu; Shuyin Wen; Kaisen Huang
Journal:  Cell Mol Neurobiol       Date:  2017-08-20       Impact factor: 5.046

Review 2.  Procalcitonin: improved biochemical severity stratification and postoperative monitoring in severe abdominal inflammation and sepsis.

Authors:  B Rau; C M Krüger; M K Schilling
Journal:  Langenbecks Arch Surg       Date:  2004-03-06       Impact factor: 3.445

3.  Increased plasma levels of pro-brain natriuretic peptide in patients with cardiovascular complications following off-pump coronary artery surgery.

Authors:  F Kerbaul; F Collart; R Giorgi; C Oddoze; P J Lejeune; C Guidon; T Caus; M Bellezza; F Gouin
Journal:  Intensive Care Med       Date:  2004-04-27       Impact factor: 17.440

4.  Markers of bacteremia in febrile neutropenic patients with hematological malignancies: procalcitonin and IL-6 are more reliable than C-reactive protein.

Authors:  M von Lilienfeld-Toal; M P Dietrich; A Glasmacher; L Lehmann; P Breig; C Hahn; I G H Schmidt-Wolf; G Marklein; S Schroeder; F Stuber
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-06-22       Impact factor: 3.267

Review 5.  Diagnostic value and prognostic implications of serum procalcitonin after cardiac surgery: a systematic review of the literature.

Authors:  Christoph Sponholz; Yasser Sakr; Konrad Reinhart; Frank Brunkhorst
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

6.  Prognostic value of procalcitonin in patients after elective cardiac surgery: a prospective cohort study.

Authors:  Matthias Klingele; Hagen Bomberg; Simone Schuster; Hans-Joachim Schäfers; Heinrich Volker Groesdonk
Journal:  Ann Intensive Care       Date:  2016-11-23       Impact factor: 6.925

7.  Procalcitonin in liver transplantation: are high levels due to donors or recipients?

Authors:  Daniel Eyraud; Saïd Ben Ayed; Marie Laure Tanguy; Corinne Vézinet; Jean Michel Siksik; Maguy Bernard; Sylvia Fratéa; Marie Movschin; Jean-Christophe Vaillant; Pierre Coriat; Laurent Hannoun
Journal:  Crit Care       Date:  2008-07-04       Impact factor: 9.097

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.